Drugs

Keyphrases

Publications

volume 84, number 6, 2024

Susan J Keam
Resmetirom: First Approval. Drugs 84 (6) (2024)
Susan J Keam
Cefepime/Enmetazobactam: First Approval. Drugs 84 (6) (2024)
Sohita Dhillon
Tegileridine: First Approval. Drugs 84 (6) (2024)
Susan J Keam
Resmetirom: First Approval. Drugs 84 (6) (2024)
Yahiya Y Syed
Ensitrelvir Fumaric Acid: First Approval. Drugs 84 (6) (2024)
Stephen J Nicholls
Therapeutic Potential of Lipoprotein(a) Inhibitors. Drugs 84 (6) (2024)
Stephen J Nicholls
Therapeutic Potential of Lipoprotein(a) Inhibitors. Drugs 84 (6) (2024)
Carlo Mario Lombardi, Pasquale Comberiati, Erminia Ridolo, Marcello Cottini, Mona-Rita Yacoub, Silvia Casagrande, Matteo Riccò, Marco Bottazzoli, Alvise Berti
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan. Drugs 84 (6) (2024)
Cindy-Lee Dennis, Daisy Radha Singla, Hilary K Brown, Katarina Savel, Crystal T Clark, Sophie Grigoriadis, Simone N Vigod
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions. Drugs 84 (6) (2024)
Sohita Dhillon
Tegileridine: First Approval. Drugs 84 (6) (2024)
Sarah A Jones, Eric F Morand
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned. Drugs 84 (6) (2024)
Thomas A Agbaedeng, Jean Jacques Noubiap, Kirsty A Roberts, Derek P Chew, Peter J Psaltis, Azmeraw T Amare
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis. Drugs 84 (6) (2024)
Sohita Dhillon
Crovalimab: First Approval. Drugs 84 (6) (2024)
Cindy-Lee Dennis, Daisy Radha Singla, Hilary K Brown, Katarina Savel, Crystal T Clark, Sophie Grigoriadis, Simone N Vigod
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions. Drugs 84 (6) (2024)
Stephen J Nicholls
Therapeutic Potential of Lipoprotein(a) Inhibitors. Drugs 84 (6) (2024)

volume 84, number 7, 2024

John A Hey, Susan Abushakra, Kaj Blennow, Eric M Reiman, Jakub Hort, Niels D Prins, Katerina Sheardova, Patrick Kesslak, Larry Shen, Xinyi Zhu, Adem Albayrak, Jijo Paul, Jean F Schaefer, Aidan Power, Martin Tolar
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease. Drugs 84 (7) (2024)
John A Hey, Susan Abushakra, Kaj Blennow, Eric M Reiman, Jakub Hort, Niels D Prins, Katerina Sheardova, Patrick Kesslak, Larry Shen, Xinyi Zhu, Adem Albayrak, Jijo Paul, Jean F Schaefer, Aidan Power, Martin Tolar
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease. Drugs 84 (7) (2024)
John A Hey, Jeremy Y Yu, Susan Abushakra, Jean F Schaefer, Aidan Power, Patrick Kesslak, Martin Tolar
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model. Drugs 84 (7) (2024)
Giancarlo De la Torre Canales, Mariana Barbosa Câmara-Souza, Malin Ernberg, Essam Ahmed Al-Moraissi, Anastasios Grigoriadis, Rodrigo Lorenzi Poluha, Maria Christidis, Hajer Jasim, Anna Lövgren, Nikolaos Christidis
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews. Drugs 84 (7) (2024)
Susan J Keam
Nogapendekin alfa Inbakicept: First Approval. Drugs 84 (7) (2024)
Giancarlo De la Torre Canales, Mariana Barbosa Câmara-Souza, Malin Ernberg, Essam Ahmed Al-Moraissi, Anastasios Grigoriadis, Rodrigo Lorenzi Poluha, Maria Christidis, Hajer Jasim, Anna Lövgren, Nikolaos Christidis
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews. Drugs 84 (7) (2024)
Yvette N Lamb
Givinostat: First Approval. Drugs 84 (7) (2024)
John A Hey, Jeremy Y Yu, Susan Abushakra, Jean F Schaefer, Aidan Power, Patrick Kesslak, Martin Tolar
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model. Drugs 84 (7) (2024)
Hannah A Blair
Zastaprazan: First Approval. Drugs 84 (7) (2024)
John A Hey, Jeremy Y Yu, Susan Abushakra, Jean F Schaefer, Aidan Power, Patrick Kesslak, Martin Tolar
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model. Drugs 84 (7) (2024)
Yahiya Y Syed
Correction: Iptacopan: First Approval. Drugs 84 (7) (2024)
Connie Kang
Sotatercept: First Approval. Drugs 84 (7) (2024)
Giancarlo De la Torre Canales, Mariana Barbosa Câmara-Souza, Malin Ernberg, Essam Ahmed Al-Moraissi, Anastasios Grigoriadis, Rodrigo Lorenzi Poluha, Maria Christidis, Hajer Jasim, Anna Lövgren, Nikolaos Christidis
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews. Drugs 84 (7) (2024)
John A Hey, Susan Abushakra, Kaj Blennow, Eric M Reiman, Jakub Hort, Niels D Prins, Katerina Sheardova, Patrick Kesslak, Larry Shen, Xinyi Zhu, Adem Albayrak, Jijo Paul, Jean F Schaefer, Aidan Power, Martin Tolar
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease. Drugs 84 (7) (2024)
Sohita Dhillon
Aprocitentan: First Approval. Drugs 84 (7) (2024)
Laurent Guilleminault, Stanislas Grassin-Delyle, Stuart B Mazzone
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough. Drugs 84 (7) (2024)
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians. Drugs 84 (7) (2024)

volume 84, number 8, 2024

Ayodele Sasegbon, Ivy Cheng, Bendix Labeit, Sriramya Lapa, Nathalie Rommel, Shaheen Hamdy
New and Evolving Treatments for Neurologic Dysphagia. Drugs 84 (8) (2024)
Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Ling-Xiao Chen, Andrew J McLachlan, Asad E Patanwala, Christopher G Maher, Chung-Wei Christine Lin, Lyn M March, Manuela Loureiro Ferreira, Stephanie Mathieson
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Drugs 84 (8) (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Sohita Dhillon
Tarlatamab: First Approval. Drugs 84 (8) (2024)
Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Ling-Xiao Chen, Andrew J McLachlan, Asad E Patanwala, Christopher G Maher, Chung-Wei Christine Lin, Lyn M March, Manuela Loureiro Ferreira, Stephanie Mathieson
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Drugs 84 (8) (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Susan J Keam
Zolbetuximab: First Approval. Drugs 84 (8) (2024)
Sohita Dhillon
Tovorafenib: First Approval. Drugs 84 (8) (2024)
Sohita Dhillon
Correction: Tegileridine: First Approval. Drugs 84 (8) (2024)
Ennio Giulio Favalli, Gabriella Maioli, Roberto Caporali
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs. Drugs 84 (8) (2024)
Task Toyoda, Kulveer Mankia
Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects. Drugs 84 (8) (2024)
Ennio Giulio Favalli, Gabriella Maioli, Roberto Caporali
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs. Drugs 84 (8) (2024)
Ennio Giulio Favalli, Gabriella Maioli, Roberto Caporali
Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs. Drugs 84 (8) (2024)
Sheridan M Hoy
Mavorixafor: First Approval. Drugs 84 (8) (2024)
Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Ling-Xiao Chen, Andrew J McLachlan, Asad E Patanwala, Christopher G Maher, Chung-Wei Christine Lin, Lyn M March, Manuela Loureiro Ferreira, Stephanie Mathieson
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Drugs 84 (8) (2024)
Susan J Keam
Tunlametinib: First Approval. Drugs 84 (8) (2024)
Zhiying Cao, Kaiyue Han, Hanting Lu, Sandalika Illangamudalige, Christina Abdel Shaheed, Ling-Xiao Chen, Andrew J McLachlan, Asad E Patanwala, Christopher G Maher, Chung-Wei Christine Lin, Lyn M March, Manuela Loureiro Ferreira, Stephanie Mathieson
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses. Drugs 84 (8) (2024)